Avecho Biotechnology Limited (OEZ) — Cash Flow-to-Debt Ratio
Avecho Biotechnology Limited (OEZ) has a Cash Flow-to-Debt Ratio of -0.88x as of December 2022, meaning its operating cash flow of €-808.80K could theoretically repay -1% of its total liabilities (€920.66K) in one year. Check Avecho Biotechnology Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Avecho Biotechnology Limited Cash Flow-to-Debt Ratio (2013–2022)
Historical debt coverage capacity for Avecho Biotechnology Limited across 10 annual periods. Also explore Avecho Biotechnology Limited (OEZ) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Avecho Biotechnology Limited (2013–2022)
Year-by-year debt coverage analysis for Avecho Biotechnology Limited. For market capitalisation and broader financial context, see market value of Avecho Biotechnology Limited.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -1.81x | €-1.67 Million | €920.66K | ▲ +58.6% |
| 2021 | -4.37x | €-3.10 Million | €709.36K | ▼ -114.8% |
| 2020 | -2.03x | €-1.42 Million | €700.17K | ▼ -196.0% |
| 2019 | 2.12x | €1.18 Million | €556.12K | ▲ +187.3% |
| 2018 | -2.43x | €-2.19 Million | €902.04K | ▲ +30.7% |
| 2017 | -3.50x | €-6.42 Million | €1.84 Million | ▲ +6.9% |
| 2016 | -3.76x | €-6.41 Million | €1.71 Million | ▲ +21.6% |
| 2015 | -4.79x | €-8.71 Million | €1.82 Million | ▼ -33.2% |
| 2014 | -3.60x | €-6.74 Million | €1.87 Million | ▲ +8.3% |
| 2013 | -3.92x | €-8.58 Million | €2.19 Million | — |